The distinct population of endothelial cells that line blood vessels in the insulin-producing "islets" of the human pancreas ...
Dr. Tycel Phillips discusses the implications of the FDA approval of Calquence plus bendamustine and Rituxan in untreated MCL ...
(AML) patients across both original and expansion cohorts remain in complete remission (CR), with a median follow-up of 20.1 months AML patients treated demonstrated one-year ...
All treated AML patients in both the original and expansion cohorts through January 17, 2025 remain in complete remission. The original cohort of AML patients has reached a median CR of 23.3 months, ...
IN8bio (INAB) announced new clinical data from the ongoing Phase 1 investigator-sponsored trial of INB-100, an allogeneic gamma-delta T cell ...
In recent days, the Armenian Bone Marrow Donor Registry (ABMDR) held two donor recruitment drives in the Los Angeles area, to ...
Despite India's vast population of 1.4 billion, the country faces a shortage of stem cell and bone marrow donors. Yet, ...
The future is bright for our bone marrow transplant program,” Dr. Hana Safah said. "We look forward to advancing blood cancer ...
The future is bright for our bone marrow transplant program,” Dr. Hana Safah said. "We look forward to advancing blood cancer ...
Accumulation of clots causes some of the most severe symptoms of sickle cell disease, including strokes, kidney failure, ...
For four decades, Ohio State blood and bone marrow transplant innovation has improved cancer care with an increasing emphasis ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback